Associated Papers
Genetic Variants in KNDy Pathway Lack Association with Premature Ovarian Insufficiency in Mexican Women: A Sequencing-Based Cohort Study.
Ruiz A et al.
Genes, 2024
A review of the existing literature on buprenorphine pharmacogenomics.
Meaden CW et al.
The Pharmacogenomics Journal, 2021
Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.
Abijo T et al.
Current Neuropharmacology, 2020
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Blum K et al.
Current Psychopharmacology, 2020
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Burns JA et al.
Frontiers in Psychiatry, 2019
Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence.
Yuanyuan J et al.
Neuroscience Letters, 2018
Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zeier Z et al.
The American Journal of Psychiatry, 2018
Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.
Cilia R et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2018
Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses.
Kringel D et al.
The Pharmacogenomics Journal, 2017
Association between gene variants and response to buprenorphine maintenance treatment.
Gerra G et al.
Psychiatry Research, 2014
TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
Ogata T et al.
Plos One, 2014
The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.
Nielsen DA et al.
Psychiatric Genetics, 2013
Analyzing Interaction of μ-, δ- and κ-opioid Receptor Gene Variants on Alcohol or Drug Dependence Using a Pattern Discovery-based Method.
Li Z et al.
Journal of Addiction Research & Therapy, 2013
Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.
Proudnikov D et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2013
The genetics of the opioid system and specific drug addictions.
Levran O et al.
Human Genetics, 2012
Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2012
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.
Yuferov V et al.
Annals of the New York Academy of Sciences, 2010
Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
Huang CJ et al.
Anaesthesia, 2008
Genetic susceptibility to heroin addiction: a candidate gene association study.
Levran O et al.
Genes, Brain, and Behavior, 2008
A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence.
Edenberg HJ et al.
Human Molecular Genetics, 2008
The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.
Zhang H et al.
Molecular Psychiatry, 2008
Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction.
Gerra G et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2007
Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
Yuferov V et al.
Pharmacogenetics, 2004
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?
Blum K et al.
Journal of Addiction Research & Therapy, 0
Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A et al.
Journal of Addictive Diseases, 0
Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran.
Soleimani Asl S et al.
Basic and Clinical Neuroscience, 0